/
Pharmaceutical preparations company · DE · FY ends Dec · 31.45% margin
Margins and capital returns are both well above average: 31.45% operating margin, ROIC at 44.83%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Negative free cash flow of -$34M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$54M
Net Income (TTM)
$22M
▲ +162.5% YoY
Op. Margin
31.45%
ROIC
44.83%
▲ +128.5pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$34M
▲ +50.5% YoY
Op. Cash Flow (FY)
-$34M
▲ +50.5% YoY
Net Debt
-$45M
Net Cash Position
Cash & Equiv.
$51M
5Y CAGR: +81.9%
Continue Research